News
-
-
-
PRESS RELEASE
Curatis discloses Corticorelin as active substance of C-PTBE-01 | Market Opportunity in PTBE expected to exceed USD 1 billion | Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog
Curatis Holding AG reveals Corticorelin as active substance of C-PTBE-01, targeting larger patient group for PTBE treatment. Strengthened team with Dr. Kirsty Crame and Dr. Timm Trenktrog. Market opportunity in PTBE surpassing USD 1 billion -
-
-
-
-
-
-